ARCHIVES

NIH Grant Funding to Use Percentiles Instead Of Priority Scores; Minimal Impact Seen By NCI

This article is from The Cancer Letter archive.

Vol. 14 No. 04 | January 22, 1988

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities

September 6, 2002

In Brief: Final appropriations for NCI Still Probably $875 Million; US-USR Drug Book Available

July 1, 1977

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

December 27, 2002

NCAB Members Flay NIH Proposals To Kill Cancer Program, Strip Board An NCI Of Special Authority

January 25, 1980

In Brief: McIntyre New AACI President, Salmon President Elect; Hubbard NCI AD; Underleider CIB Chief

September 30, 1988

GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL

July 26, 2013